Dr Christopher Boshkos, MD | |
411 E Market St, Akron, OH 44304-1542 | |
(330) 252-0600 | |
(330) 252-0700 |
Full Name | Dr Christopher Boshkos |
---|---|
Gender | Male |
Speciality | Internal Medicine - Nephrology |
Location | 411 E Market St, Akron, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538160924 | NPI | - | NPPES |
0664419 | Medicaid | OH | |
390005139 | Other | OH | RR MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 35-04-6178-B (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Christopher Boshkos, MD 411 E Market St, Akron, OH 44304-1542 Ph: (330) 252-0600 | Dr Christopher Boshkos, MD 411 E Market St, Akron, OH 44304-1542 Ph: (330) 252-0600 |
News Archive
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, today announced that it has closed on a $10 million tranche of a Series B financing, based on substantial progress with the company's product pipeline including advancing the lead product candidate, TT30, toward clinical development.
Healthcare-associated infections represent a growing concern for both patients and healthcare providers across the nation. The Centers for Disease Control and Prevention estimates that approximately 1.7 million HAIs occur each year and contribute to the death of 99,000.
When the debate over the fiscal 2012 budget began, the country — or, more accurately, the media — was focused on Rep. Paul Ryan's proposal. Introduced on behalf of the Republican House majority, our colleague's plan puts the interests of wealthy corporations first by slashing Medicare and Medicaid and spending trillions on a new corporate tax cut. Indeed, cutting is all it seems to do. ... That's not a jobs plan — that's an economic death sentence.
Melior Discovery, Inc. announced today the United States Patent and Trademark Office (USTPO) has awarded a Notice of Allowance for a broad patent application covering the Company's use of MLR-1023 for, among other things, the treatment of type II diabetes and obesity. The patent will cover use of MLR-1023 for the treatment of type II diabetes, obesity and metabolic syndrome, including its use in combination with other compounds and as a component in other drugs.
The prevalence of throat (oropharyngeal) cancers caused by the human papilloma virus (HPV) has increased in recent decades, and some groups are much more likely than others to have the oral HPV infections that can cause these cancers.
› Verified 3 days ago
Dr. Michael A Pelini, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Ste 300, Akron, OH 44304 Phone: 330-376-7000 Fax: 330-376-1066 | |
David P. Lang, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #200c, Akron, OH 44333 Phone: 330-665-8031 Fax: 330-665-8360 | |
Ms. Tiffany Mccann, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3561 | |
Jonathan Buggey, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St Ste 300, Akron, OH 44304 Phone: 724-422-6808 | |
Shamsa Baaj, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Mira Rohit Patel, DO Nephrology Medicare: Medicare Enrolled Practice Location: 161 N Forge St Ste 198, Akron, OH 44304 Phone: 330-375-3039 | |
Richard J Streck, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, 5th Floor Ambulatory Care Center, Akron, OH 44307 Phone: 330-344-6015 Fax: 330-344-6820 |